Guidelines update, v35.1
4 March, 2021
Updates to the Australian guidelines for the clinical care of people with COVID-19 this week include: Tocilizumab - The references for REMAP-CAP and COVACTA (Rosas et al.) trials have been updated to reflect the published versions of the previously pre-print only articles - there was no change to the strength or direction of recommendation. Convalescent plasma - Text within the ‘summary’...